Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.

Literature DB >> 805209

Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.

Abstract

During blood coagulation ultrastructural lesions were produced on the platelet membrane. They were dependent on the presence of both thrombin and complement (C) and were morphologically identical to the C-dependent ultrastructural lesions (type II) seen in red cells subsequent to activation of C by the alternate mechanismmthough similar in shape they differed in size from ultrastructural lesions (type I) PRODUCED BY ACTIVATION OF C via the classic mechanismmlesions of type I were seen on the platelet surface subsequent to antibody-dependent activation of the C system.

Entities: Disease Gene

Mesh：

Substances：

Year: 1975 PMID： 805209 PMCID： PMC2189843 DOI： 10.1084/jem.141.6.1261

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

9 in total

1. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors: C F HINZ; W S JORDAN; L PILLEMER
Journal: J Clin Invest Date: 1956-05 Impact factor: 14.808

2. Aggregation and release reaction induced in human blood platelets by zymosan.

Authors: M B Zucker; R A Grant
Journal: J Immunol Date: 1974-03 Impact factor: 5.422

3. Iodination of the human platelet membrane. Studies of the major surface glycoprotein.

Authors: R L Nachman; A Hubbard; B Ferris
Journal: J Biol Chem Date: 1973-04-25 Impact factor: 5.157

4. Production of in vitro lytic characteristics of paroxysmal nocturnal hemoglobinuria erythrocytes in normal erythrocytes.

Authors: H E Kann; C E Mengel; W D Meriwether; L Ebbert
Journal: Blood Date: 1968-07 Impact factor: 22.113

5. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors: P Cuatrecasas
Journal: J Biol Chem Date: 1970-06 Impact factor: 5.157

6. The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

Authors: N R Cooper; M J Polley; H J Müller-Eberhard
Journal: Immunochemistry Date: 1970-04

7. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

Authors: O Götze; H J Müller-Eberhard
Journal: N Engl J Med Date: 1972-01-27 Impact factor: 91.245

8. A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.

Authors: T S Zimmerman; C M Arroyove; H J Müller-Eberhard
Journal: J Exp Med Date: 1971-12-01 Impact factor: 14.307

9. Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.

Authors: Esin Güven; Karen Duus; Inga Laursen; Peter Højrup; Gunnar Houen
Journal: PLoS One Date: 2013-09-09 Impact factor: 3.240

9 in total

Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.

1. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

2. Aggregation and release reaction induced in human blood platelets by zymosan.

3. Iodination of the human platelet membrane. Studies of the major surface glycoprotein.

4. Production of in vitro lytic characteristics of paroxysmal nocturnal hemoglobinuria erythrocytes in normal erythrocytes.

5. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

6. The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

7. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

8. A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.

9. Blood coagulation initiation by a complement-mediated pathway.

1. The platelet as an inflammatory cell.

Review 2. Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

3. Complement activation by aluminium and zirconium compounds.

4. Abnormal platelet function in C3-deficient mice.

5. The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

6. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.

7. The human complement system in thrombin-mediated platelet function.

8. Human complement in the arachidonic acid transformation pathway in platelets.

9. Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.